Key result
Anredera cordifolia leaf extracts consistently lower blood pressure via ACE inhibition and nitric oxide vasodilation.
Why the study?
The use of natural ingredients such as Anredera cordifolia (binahong plant) as adjunctive therapy for hypertension continues to grow, motivating a synthesis of preclinical and clinical evidence on its antihypertensive potential.
Does Anredera cordifolia leaf extract or preparation reduce systolic and diastolic blood pressure in preclinical models and human participants with hypertension?
Does Anredera cordifolia leaf extract or preparation reduce systolic and diastolic blood pressure in preclinical models and human participants with hypertension?
Answers are grounded in this paper and cite their sources.
This narrative review synthesizes preclinical and preliminary human evidence indicating that Anredera cordifolia leaves possess multitargeted antihypertensive properties, though rigorous randomized controlled trials are required to establish standardized clinical dosing and safety.
Hypertension is a condition that develops gradually but can suddenly lead to serious consequences, including death. The use of natural ingredients as adjunctive therapy continues to grow, including Anredera cordifolia, more commonly known as the binahong plant. Ethanol extracts of A. cordifolia leaves are known to contain vitexin (flavonoids), tannins, saponins, betalains, betanidin (alkaloids), phenols, terpenoids, and ursolic acid. A narrative review was conducted to identify relevant studies published in PubMed, Scopus, and Google Scholar databases between 2016 and 2026. The search terms related to “Anredera” AND “Hypertensive” found 625 articles. Following the screening of titles and abstracts and subsequent full-text assessment based on the predefined inclusion and exclusion criteria, 15 articles were considered eligible and included in the review. The articles consistently demonstrated that A. cordifolia leaves exhibit antihypertensive effects in vitro, ex vivo, in vivo, and through empirical use in humans. In humans, it lowers both systolic and diastolic blood pressure. These antihypertensive activities occur through several mechanisms, including inhibition of angiotensin-converting enzyme (ACE), vasodilatory effects via the nitric oxide (NO) pathway, inhibition of angiotensin type 1 receptors and adrenergic receptors, and as a (weak) diuretic. This presents an opportunity to develop traditional medicine as an adjunct to antihypertensive therapy. However, further clinical research is still needed to confirm its efficacy, safety, and optimal dosage for human use.
No takes yet. Share an insight, caveat, or question.
Sagita et al. (2026) conducted a review in Hypertension. Anredera cordifolia (binahong) leaf extracts, fractions, infusions, or decoctions vs. Control groups, standard antihypertensive drugs (amlodipine, atenolol, furosemide, terazosin) in preclinical models, or red ginger rhizome infusion in human studies was evaluated on Systolic and diastolic blood pressure reduction and antihypertensive activity. Anredera cordifolia leaf extracts and decoctions consistently lowered systolic and diastolic blood pressure across 15 preclinical and human studies via ACE inhibition and nitric oxide vasodilation.
Synapse has enriched 10 related papers. Consider them for comparative context: